Metformin Does Not Cause Depression
Based on the most recent and highest quality evidence, metformin does not cause depression and may actually protect against it in adults with type 2 diabetes. The 2025 guidelines and FDA labeling do not list depression as a recognized side effect of metformin 1, 2.
Key Evidence on Metformin and Depression
What the Guidelines and FDA Say
The most recent 2025 American Diabetes Association guidelines explicitly state that metformin's principal side effects are gastrointestinal intolerance (bloating, abdominal discomfort, diarrhea), vitamin B12 deficiency, and worsening neuropathy symptoms 1. Depression is notably absent from this list.
The FDA drug label for metformin similarly does not include depression or mood changes among its adverse effects 2. The recognized serious side effect is lactic acidosis, with common side effects being gastrointestinal.
Recent Research Shows Protective Effects
The most recent 2025 research actually demonstrates that metformin use significantly reduces the risk of depression in people with type 2 diabetes (hazard ratio 0.771,95% CI: 0.649-0.916), with prevention of 1 case of depression per 1000 patients taking metformin for approximately 8 months 3. Another 2024 longitudinal study found that metformin treatment improved depressive symptoms over 24 weeks in patients with type 2 diabetes who had concomitant depression 4.
The Vitamin B12 Connection - A Critical Caveat
The key mechanism by which metformin could indirectly contribute to depression is through vitamin B12 deficiency, not through direct causation. Here's what you need to know:
- Metformin use is associated with vitamin B12 deficiency 1
- Vitamin B12 deficiency itself can cause depression and cognitive impairment 5
- A 2015 study found that cobalamin-deficient patients on metformin had a 2.4 times higher chance of depression compared to those with sufficient B12 levels 5
This means the depression risk is mediated through B12 deficiency, not metformin directly.
Clinical Algorithm for Managing This Issue
1. Screen for B12 Deficiency
- Check vitamin B12 levels periodically in all patients on metformin 1
- Consider checking at baseline and annually thereafter
- Be especially vigilant in patients with neuropathy symptoms or mood changes
2. Supplement When Deficient
- If B12 is low (<148 pmol/L), supplement appropriately
- This should resolve any depression related to B12 deficiency 5
3. Monitor for Depression Risk Factors
The 2025 cohort study identified that screening for depression should begin within 1-2 years of metformin initiation and focus on 6:
- Females (2-fold higher risk)
- Those <55 years old
- History of mental health conditions
- Multiple comorbid conditions
- Frequent healthcare utilization
4. Consider Metformin's Potential Benefits
If a patient with type 2 diabetes has depression, metformin may actually be beneficial rather than harmful 3, 4. The 2025 mechanistic review suggests metformin helps reduce depressive symptoms through multiple pathways including neurotransmitter regulation, enhanced neurogenesis, anti-inflammatory effects, and gut microbiota changes 7.
Important Contradictory Evidence to Note
One 2023 observational study reported increased depression scores in patients taking metformin 8. However, this study has significant limitations:
- Small sample size (only 30 patients per group)
- Observational design without controlling for B12 status
- Published in a lower-tier journal
- Contradicted by multiple larger, more recent studies 3, 4
This outlier study should not change clinical practice given the weight of higher-quality evidence showing protective or neutral effects.
Bottom Line for Clinical Practice
Do not discontinue or avoid metformin due to depression concerns. Instead:
- Monitor and supplement vitamin B12 levels regularly
- Screen for depression in high-risk patients (females, younger age, multiple comorbidities) within 1-2 years of starting metformin
- Consider that metformin may actually improve depressive symptoms in patients with type 2 diabetes
- The established benefits of metformin (cardiovascular mortality reduction, microvascular complication prevention, weight neutrality) far outweigh any theoretical depression risk 1